Achaogen (AKAO) Misses Q3 EPS by 2c

Achaogen (NASDAQ: AKAO) reported Q3 EPS of ($1.02), $0.02 worse than the analyst estimate of ($1.00). Revenue for the quarter came in at $2 million versus the consensus estimate of $3.78 million.

For earnings history and earnings-related data on Achaogen (AKAO) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Tops Q2 EPS by 24c
• Quantum BioPharma gets FDA nod for Lucid-MS Phase 2 MS trial